Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Request a free trial

No credit card. No commitment.

Plans and Pricing

Reach a Targeted Audience

The free Patent Expiration Bulletin is your vehicle to reach a targeted pharmaceutical industry audience. Subscribers include:

  • Big pharma
  • Domestic and international generic firms
  • Healthcare payers
  • Federal and state government agencies
  • Distributors, wholesalers, and pharmacies
  • Lawyers and consultants

The bulletin is sent to more than 15,000 opt-in readers every week, resulting in tens of thousands of monthly exposures. It is your opportunity to reach your audience by permission marketing; direct to their inboxes.

See a sample newsletter (opens in new window)

Contact admin@DrugPatentWatch.com for more information or to place an insertion order.

List Rental

Email blast: $6,995
Send your rich-text HTML message to the entire list.

Banners Ads

728 x 90 — $995 / insertion

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc